Fluorination Strategy for Benzimidazole Core Based Electron Acceptors Achieving over 19% Efficiency for Ternary Organic Solar Cells.

ACS Appl Mater Interfaces

Beijing Advanced Innovation Center for Soft Matter Science and Engineering & State Key Laboratory of Organic-Inorganic Composites, Beijing University of Chemical Technology, Beijing 100029, P. R. China.

Published: December 2024

The expansion of two-dimensional conjugated systems in nonfullerene electron acceptors (NFAs) has significantly advanced the molecular design and efficiency potential of organic solar cells (OSCs). This study introduces a novel class of NFAs featuring a benzimidazole core with varying degrees of peripheral fluorination, designated as YIS-4F, YIS-6F, and YIS-8F, respectively. Through systematic modulation of fluorine content, we observed that OSCs incorporating YIS-6F achieved the highest power conversion efficiency (PCE) of 17.28%, surpassing those with YIS-4F and YIS-8F. Notably, the incorporation of YIS-6F in a ternary blend with D18/N3 yielded a remarkable PCE of 19.43%. The enhanced performance of YIS-6F-based devices is attributed to the optimized energy level alignment and optimized crystallinity, which collectively facilitate efficient exciton dissociation, accelerated charge transport, and minimized charge recombination, culminating in an exceptional fill factor and PCE. Our findings underscore the pivotal role of fluorination of NFAs at the central benzimidazole core in optimizing molecular packing, and consequently enhancing the performance of OSCs.

Download full-text PDF

Source
http://dx.doi.org/10.1021/acsami.4c16494DOI Listing

Publication Analysis

Top Keywords

benzimidazole core
12
electron acceptors
8
organic solar
8
solar cells
8
fluorination strategy
4
strategy benzimidazole
4
core based
4
based electron
4
acceptors achieving
4
achieving 19%
4

Similar Publications

Heterocyclic compounds are increasingly used in medicinal chemistry because they are the main components of many biological processes and materials. Benzimidazole remains the core center of the heterocyclic chemical group, with essential traits such as six-five-member connected rings and two nitrogen atoms at the 1,3 position in a six-membered benzene and five-membered imidazole- fused ring system. Molecules with benzimidazole derivatives serve important functions as therapeutic agents and have shown excellent results in clinical and biological research.

View Article and Find Full Text PDF

Background And Aims: Pan-genotypic ribavirin-free oral direct-acting antivirals, including the glecaprevir/pibrentasvir combination, are recommended for the treatment of most patients with chronic hepatitis C virus (HCV) infection. In Romania, the HCV-infected patient population receiving glecaprevir/pibrentasvir is not well characterized and data on treatment effectiveness is lacking. The ODYSSEY study aimed to provide insights into the characteristics and treatment outcomes of HCV-infected Romanian patients receiving 8-week therapy with glecaprevir/pibrentasvir.

View Article and Find Full Text PDF

Fluorination Strategy for Benzimidazole Core Based Electron Acceptors Achieving over 19% Efficiency for Ternary Organic Solar Cells.

ACS Appl Mater Interfaces

December 2024

Beijing Advanced Innovation Center for Soft Matter Science and Engineering & State Key Laboratory of Organic-Inorganic Composites, Beijing University of Chemical Technology, Beijing 100029, P. R. China.

The expansion of two-dimensional conjugated systems in nonfullerene electron acceptors (NFAs) has significantly advanced the molecular design and efficiency potential of organic solar cells (OSCs). This study introduces a novel class of NFAs featuring a benzimidazole core with varying degrees of peripheral fluorination, designated as YIS-4F, YIS-6F, and YIS-8F, respectively. Through systematic modulation of fluorine content, we observed that OSCs incorporating YIS-6F achieved the highest power conversion efficiency (PCE) of 17.

View Article and Find Full Text PDF

Circumventing Imatinib resistance in CML: Novel Telmisartan-based cell death modulators with improved activity and stability.

Eur J Med Chem

February 2025

Department of Internal Medicine V, Hematology and Oncology, Tyrolean Cancer Research Institute (TKFI), Comprehensive Cancer Center Innsbruck (CCCI), Medical University of Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria. Electronic address:

Drug resistance presents a significant challenge in cancer therapy, which has led to intensive research in resistance mechanisms and new therapeutic strategies. In chronic myeloid leukemia (CML), the introduction of Imatinib, the first tyrosine kinase inhibitor (TKI), drastically changed the outcome for patients. However, complete remission still cannot be achieved in a large number of patients in the long term.

View Article and Find Full Text PDF

Background: Opisthorchis viverrini (OV) and soil-transmitted helminths (STH) are two of the most common helminths contributing to the Neglected Tropical Disease (NTDs) burden in the Lower Mekong Basin. Although mass drug administration is the cornerstone of control programs to reduce morbidity caused by these infections, this approach has limitations in preventing re-infections. Elimination requires additional measures such as reservoir host treatment, improved hygiene and health education to reinforce MDA's impact.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!